Life Changing, Re-Dosable Gene Therapies: we are committed to longer, healthier lives for all, including kids and adults who can’t currently be treated. With EVADER™, our next generation, AAV based gene therapy platform technology we are addressing the limitations of current alternatives.
Investors 5
| Date | Name | Website |
| - | Life Scien... | lifescienc... |
| - | Berkeley S... | skydeck.be... |
| - | Tachyon Ve... | tachyon.vc |
| - | Cantos Ven... | cantos.vc |
| - | Solasta Ve... | solasta-ve... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 19.07.2022 | Chameleon Biosciences Founder to Speak at Next Generation Ge... | Immunology and gene therapy CEO and scientist presents innovative vector modifications at industry s... | einpresswi... |
| 29.04.2022 | Chameleon Biosciences, Inc. Founder CEO, Genine Winslow on h... | Genine Winslow, Founder CEO, Chameleon Biosciences, Inc. CEOCFO I Interviews Chameleon Biosciences,... | einpresswi... |